Top Markets
Coin of the day
Minerva Surgical, Inc. Minerva Surgical, Inc.

Minerva Surgical, Inc.

UTRS
Rangering i aksjer #42552
Minerva Surgical, Inc. functions as a commercial-stage medical technology... Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$888.00
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Minerva Surgical, Inc. (UTRS)

Kategori

P/B-forhold for Minerva Surgical, Inc. (UTRS)
P/B-forhold per 2026 TTM: 0
Ifølge Minerva Surgical, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Minerva Surgical, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter